μ-Heavy Chain Disease Associated with Systemic Amyloidosis

Author： Kinoshita Koji Yamagata Toshiaki Nozaki Yuji Sugiyama Masafumi Ikoma Shinya Funauchi Masanori Kanamaru Akihisa

ISSN： 1024-5332

Source： Hematology, Vol.9, Iss.2, 2004-04, pp. : 135-137

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Localized Castleman’s disease associated with systemic AA amyloidosis. Regression of amyloid deposits after tumor removal

By Androulaki A. Giaslakiotis K. Giakoumi X. Aessopos A. Lazaris A.

Annals of Hematology, Vol. 86, Iss. 1, 2007-01 ,pp. : 55-57

Springer Publishing Company

Access to resources Recommend Favorite

Systemic amyloidosis complicated with peliosis

By Tsutsumi Yutaka

Annals of Hematology, Vol. 88, Iss. 9, 2009-09 ,pp. : 917-920

Springer Publishing Company

Access to resources Recommend Favorite

Nutritional status independently affects quality of life of patients with systemic immunoglobulin light-chain (AL) amyloidosis

By Caccialanza Riccardo Palladini Giovanni Klersy Catherine Cereda Emanuele Bonardi Chiara Cameletti Barbara Montagna Elisabetta Russo Paola Foli Andrea Milani Paolo Lavatelli Francesca Merlini Giampaolo

Annals of Hematology, Vol. 91, Iss. 3, 2012-03 ,pp. : 399-406

Springer Publishing Company

Access to resources Recommend Favorite

Does the CDR3 of the Heavy Chain Determine the Specificity of Autoantibodies in Systemic Lupus Erythematosus?

By Yazici Z.A. Behrendt M. Goodfield M. Partridge L.J. Lindsey N.J.

Journal of Autoimmunity, Vol. 11, Iss. 5, 1998-10 ,pp. : 477-483

Academic Press

Access to resources Recommend Favorite

An Ig -heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB × NZW)F 1 mice

By Wellmann Ute

International Immunology, Vol. 13, Iss. 12, 2001-12 ,pp. : 1461-1469

Oxford University Press

Access to resources Recommend Favorite